Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 76

    1.

    Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants II: role of plasma esterases in drug release.

    Lu X, Howard MD, Talbert DR, Rinehart JJ, Potter PM, Jay M, Leggas M.

    AAPS J. 2009 Mar;11(1):120-2. Epub 2009 Feb 19. No abstract available. PMID: 19225893 [PubMed - indexed for MEDLINE]Related articles

    2.

    Mammalian mitochondria have the innate ability to import tRNAs by a mechanism distinct from protein import.

    Rubio MA, Rinehart JJ, Krett B, Duvezin-Caubet S, Reichert AS, Söll D, Alfonzo JD.

    Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9186-91. Epub 2008 Jun 27.PMID: 18587046 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants: optimization and in vitro characterization.

    Lu X, Howard MD, Mazik M, Eldridge J, Rinehart JJ, Jay M, Leggas M.

    AAPS J. 2008;10(1):133-40. Epub 2008 Mar 4.PMID: 18446513 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Dexamethasone as a chemosensitizer for breast cancer chemotherapy: potentiation of the antitumor activity of adriamycin, modulation of cytokine expression, and pharmacokinetics.

    Wang H, Wang Y, Rayburn ER, Hill DL, Rinehart JJ, Zhang R.

    Int J Oncol. 2007 Apr;30(4):947-53.PMID: 17332934 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effect of docetaxel chemotherapy on the activity of a gonadotropin releasing hormone vaccine in patients with advanced prostate cancer.

    Triozzi PL, Bolger GB, Neidhart J, Rinehart JJ, Saleh M, Allen KO, Sellers S, Waddell MJ.

    Prostate. 2005 Dec 1;65(4):316-21.PMID: 16015596 [PubMed - indexed for MEDLINE]Related articles

    7.

    Dexamethasone as a chemoprotectant in cancer chemotherapy: hematoprotective effects and altered pharmacokinetics and tissue distribution of carboplatin and gemcitabine.

    Wang H, Li M, Rinehart JJ, Zhang R.

    Cancer Chemother Pharmacol. 2004 Jun;53(6):459-67. Epub 2004 Jan 30.PMID: 14752578 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of HER2/neu expression on survival in non-small-cell lung cancer.

    Korrapati V, Gaffney M, Larsson LG, Di Nunno L, Riggs M, Beissner RS, Rinehart JJ, Mott FE.

    Clin Lung Cancer. 2001 Feb;2(3):216-9.PMID: 14700481 [PubMed]Related articlesFree article

    9.

    Gene expression of insulin-like growth factors and receptors in neoplastic prostate tissues: correlation with clinico-pathological parameters.

    Figueroa JA, De Raad S, Speights VO, Rinehart JJ.

    Cancer Invest. 2001;19(1):28-34.PMID: 11291553 [PubMed - indexed for MEDLINE]Related articles

    10.

    Estrogen and progesterone receptors in non-small cell lung cancer in 248 consecutive patients who underwent surgical resection.

    Di Nunno L, Larsson LG, Rinehart JJ, Beissner RS.

    Arch Pathol Lab Med. 2000 Oct;124(10):1467-70.PMID: 11035577 [PubMed - indexed for MEDLINE]Related articles

    11.

    Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience.

    Galanis E, Hersh EM, Stopeck AT, Gonzalez R, Burch P, Spier C, Akporiaye ET, Rinehart JJ, Edmonson J, Sobol RE, Forscher C, Sondak VK, Lewis BD, Unger EC, O'Driscoll M, Selk L, Rubin J.

    J Clin Oncol. 1999 Oct;17(10):3313-23.PMID: 10506635 [PubMed - indexed for MEDLINE]Related articles

    12.

    Lack of CNS penetration of docetaxel in a patient with leptomeningeal carcinomatosis.

    Herrington JD, Di Nunno L, Rinehart JJ.

    Ann Pharmacother. 1998 May;32(5):611-2. No abstract available. PMID: 9606487 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pituitary component of the aromatic hydrocarbon-mediated expression of CYP2B and CYP2C11.

    Bergeron RM, Serron SC, Rinehart JJ, Cawley GF, Backes WL.

    Xenobiotica. 1998 Mar;28(3):303-12.PMID: 9574818 [PubMed - indexed for MEDLINE]Related articles

    14.

    Differential expression of insulin-like growth factor binding proteins in high versus low Gleason score prostate cancer.

    Figueroa JA, De Raad S, Tadlock L, Speights VO, Rinehart JJ.

    J Urol. 1998 Apr;159(4):1379-83.PMID: 9507888 [PubMed - indexed for MEDLINE]Related articles

    15.

    Reduction in carboplatin hematopoietic toxicity in tumor bearing mice: comparative mechanisms and effects of interleukin-1 beta and corticosteroids.

    Rinehart JJ, Keville LR.

    Cancer Biother Radiopharm. 1997 Apr;12(2):101-9.PMID: 10851453 [PubMed - indexed for MEDLINE]Related articles

    16.

    Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.

    Figlin RA, Crowley JJ, Jacobs EL, Muirhead M, Goodwin JW, Rinehart JJ, Livingston RB.

    Cancer. 1996 Sep 1;78(5):998-1003.PMID: 8780537 [PubMed - indexed for MEDLINE]Related articles

    17.

    Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study.

    Budd GT, Green S, O'Bryan RM, Martino S, Abeloff MD, Rinehart JJ, Hahn R, Harris J, Tormey D, O'Sullivan J, et al.

    J Clin Oncol. 1995 Apr;13(4):831-9.PMID: 7707108 [PubMed - indexed for MEDLINE]Related articles

    18.

    Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study.

    Bukowski RM, Tangen CM, Peterson RF, Taylor SA, Rinehart JJ, Eyre HJ, Rivkin SE, Fleming TR, Macdonald JS.

    Cancer. 1994 Mar 1;73(5):1505-8.PMID: 8111718 [PubMed - indexed for MEDLINE]Related articles

    19.

    GM-CSF, carboplatin, doxorubicin: a phase I study.

    Poplin EA, Alberts DS, Rinehart JJ, Smith HO, Neidhart JA, Hersh EM.

    Cancer Chemother Pharmacol. 1994;33(4):340-6.PMID: 8281628 [PubMed - indexed for MEDLINE]Related articles

    20.

    Aci-reductones enhance interleukin-2-induced lymphocyte cytotoxicity.

    Triozzi PL, Ailabouni J, Rinehart JJ, Witiak DT.

    Int J Immunopharmacol. 1993 Jan;15(1):47-54.PMID: 8432623 [PubMed - indexed for MEDLINE]Related articles

    21.

    Lack of significant changes in nutrition-related parameters with tumor necrosis factor treatment of cancer.

    Hurley RS, O'Dorisio TM, Rinehart JJ, Welch MA, Geraghty ME, Nahikian-Nelms M, Kinney P, Rice RR.

    Nutr Cancer. 1993;19(3):253-61.PMID: 8346074 [PubMed - indexed for MEDLINE]Related articles

    22.

    Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1.

    Triozzi PL, Eicher DM, Smoot J, Rinehart JJ.

    Exp Hematol. 1992 Oct;20(9):1072-6.PMID: 1361453 [PubMed - indexed for MEDLINE]Related articles

    23.

    Modulation of hematologic and immunologic effects of high dose chemotherapy by interleukin-2 in a murine tumor model.

    Rinehart JJ, Triozzi PL, Lee MH, Aldrich W, Young D.

    Mol Biother. 1992 Jun;4(2):77-82.PMID: 1515098 [PubMed - indexed for MEDLINE]Related articles

    24.

    A Southwest Oncology Group Phase I study of the sequential combination of recombinant interferon-gamma and recombinant interleukin-2 in patients with cancer.

    Taylor CW, Chase EM, Whitehead RP, Rinehart JJ, Neidhart JA, Gonzalez R, Bunn PA, Hersh EM.

    J Immunother (1991). 1992 Apr;11(3):176-83.PMID: 1515422 [PubMed - indexed for MEDLINE]Related articles

    25.

    Modulation of adhesion molecules on human large granular lymphocytes by interleukin-2 in vivo and in vitro.

    Triozzi PL, Eicher DM, Rinehart JJ.

    Cell Immunol. 1992 Apr;140(2):295-303.PMID: 1347485 [PubMed - indexed for MEDLINE]Related articles

    26.

    Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience.

    Hersh EM, Metch BS, Muggia FM, Brown TD, Whitehead RP, Budd GT, Rinehart JJ, Crawford ED, Bonnet JD, Behrens BC.

    J Immunother (1991). 1991 Dec;10(6):426-31.PMID: 1768676 [PubMed - indexed for MEDLINE]Related articles

    27.

    Phase II study of intravenous bolus recombinant interleukin-2 in advanced malignant melanoma: Southwest Oncology Group study.

    Whitehead RP, Kopecky KJ, Samson MK, Costanzi JJ, Natale RB, Feun LG, Hersh EM, Rinehart JJ.

    J Natl Cancer Inst. 1991 Sep 4;83(17):1250-2. No abstract available. PMID: 1870152 [PubMed - indexed for MEDLINE]Related articles

    28.

    Vinblastine fails to improve response of renal cancer to interferon alfa-n1: high response rate in patients with pulmonary metastases.

    Neidhart JA, Anderson SA, Harris JE, Rinehart JJ, Laszlo J, Dexeus FH, Einhorn LH, Trump DL, Benedetto PW, Tuttle RL, et al.

    J Clin Oncol. 1991 May;9(5):832-6.PMID: 2016626 [PubMed - indexed for MEDLINE]Related articles

    29.

    Human monocytes inhibit lymphokine-activated killer cell expansion in vitro.

    Triozzi PL, Aldrich WA, Rinehart JJ.

    Mol Biother. 1991 Mar;3(1):22-5.PMID: 2069757 [PubMed - indexed for MEDLINE]Related articles

    30.

    Biological and clinical effects of interferon-beta ser at two doses.

    Borden EC, Rinehart JJ, Storer BE, Trump DL, Paulnock DM, Teitelbaum AP.

    J Interferon Res. 1990 Dec;10(6):559-70.PMID: 2086672 [PubMed - indexed for MEDLINE]Related articles

    31.

    Spleen cell population changes and hemolytic anemia in F344 rats with large granular lymphocyte leukemia.

    Stromberg PC, Kociba GJ, Grants IS, Krakowka GS, Rinehart JJ, Mezza LE.

    Vet Pathol. 1990 Nov;27(6):397-403.PMID: 2148994 [PubMed - indexed for MEDLINE]Related articles

    32.

    Immunological effects of flavone acetic acid.

    Triozzi PL, Rinehart JJ, Malspeis L, Young DC, Grever MR.

    Cancer Res. 1990 Oct 15;50(20):6483-5.PMID: 2208107 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Phase I study of repeated cycles of high-dose cyclophosphamide, etoposide, and cisplatin administered without bone marrow transplantation.

    Neidhart JA, Kohler W, Stidley C, Mangalik A, Plauche A, Anderson T, Quenzer RW, Rinehart JJ.

    J Clin Oncol. 1990 Oct;8(10):1728-38.PMID: 2213108 [PubMed - indexed for MEDLINE]Related articles

    34.

    Tumor necrosis factor infusions in humans prime neutrophils for hypochlorous acid production.

    Wewers MD, Rinehart JJ, She ZW, Herzyk DJ, Hummel MM, Kinney PA, Davis WB.

    Am J Physiol. 1990 Oct;259(4 Pt 1):L276-82.PMID: 2171355 [PubMed - indexed for MEDLINE]Related articles

    35.

    Phase II trial of interferon-beta-serine in metastatic renal cell carcinoma.

    Kinney P, Triozzi P, Young D, Drago J, Behrens B, Wise H, Rinehart JJ.

    J Clin Oncol. 1990 May;8(5):881-5.PMID: 2332772 [PubMed - indexed for MEDLINE]Related articles

    36.

    Inhibition of in vitro plaque formation by large granular lymphocyte leukemia cells from F344 rats.

    Stromberg PC, Grants IS, Reiter JA, Krakowka GS, Kociba GJ, Mezza LE, Rinehart JJ.

    J Clin Lab Immunol. 1990 Jan;31(1):27-31.PMID: 1966981 [PubMed - indexed for MEDLINE]Related articles

    37.

    Central nervous system toxicity of biological response modifiers.

    Triozzi PL, Kinney P, Rinehart JJ.

    Ann N Y Acad Sci. 1990;594:347-54. Review. No abstract available. PMID: 1696080 [PubMed - indexed for MEDLINE]Related articles

    39.

    Open-label phase II trial of recombinant beta interferon (IFN-beta (ser)) in patients with colorectal cancer.

    Triozzi PL, Kenney P, Young D, Rinehart JJ.

    Cancer Treat Rep. 1987 Oct;71(10):983-4. No abstract available. PMID: 3308083 [PubMed - indexed for MEDLINE]Related articles

    40.

    Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study.

    Al-Sarraf M, Metch B, Kish J, Ensley J, Rinehart JJ, Schuller DE, Coltman CA Jr.

    Cancer Treat Rep. 1987 Jul-Aug;71(7-8):723-6.PMID: 3300967 [PubMed - indexed for MEDLINE]Related articles

    41.

    Phase I/II trial of recombinant gamma-interferon in patients with renal cell carcinoma: immunologic and biologic effects.

    Rinehart JJ, Young D, Laforge J, Colburn D, Neidhart J.

    J Biol Response Mod. 1987 Jun;6(3):302-12.PMID: 3110379 [PubMed - indexed for MEDLINE]Related articles

    42.

    Phase I/II trial of interferon-beta-serine in patients with renal cell carcinoma: immunological and biological effects.

    Rinehart JJ, Young D, Laforge J, Colborn D, Neidhart JA.

    Cancer Res. 1987 May 1;47(9):2481-5.PMID: 3567933 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Weight change and peptide hormone responses in patients receiving interferon.

    Hurley RS, O'Dorisio TM, Bossetti BM, Rinehart JJ, Rice RR, Neidhart JA.

    Nutr Cancer. 1987;10(1-2):89-94.PMID: 3112748 [PubMed - indexed for MEDLINE]Related articles

    44.

    Impact of metastases on nodal immunoreactivity in head and neck cancer.

    Schuller DE, Koolemans-Beynen AR, Libby DH, Rinehart JJ, Milo GE.

    Laryngoscope. 1986 Nov;96(11):1189-92.PMID: 3773614 [PubMed - indexed for MEDLINE]Related articles

    45.

    Induction of lymphokine-activated killer cells in strain 2 guinea pigs with human interleukin-2.

    Zwilling BS, Aldrich WA, Rinehart JJ.

    Cancer Res. 1986 Nov;46(11):5667-70.PMID: 3489527 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    T-lymphocytes as a prognostic indicator in head and neck cancer.

    Schuller DE, Rock RP, Rinehart JJ, Koolemans-Beynen AR.

    Arch Otolaryngol Head Neck Surg. 1986 Sep;112(9):938-41.PMID: 3488752 [PubMed - indexed for MEDLINE]Related articles

    47.

    Phase I/II trial of human recombinant interferon gamma in renal cell carcinoma.

    Rinehart JJ, Malspeis L, Young D, Neidhart JA.

    J Biol Response Mod. 1986 Aug;5(4):300-8.PMID: 3090208 [PubMed - indexed for MEDLINE]Related articles

    48.

    The effect of gamma interferon on IL-1 secretion of in vitro differentiated human macrophages.

    Haq AU, Rinehart JJ, Maca RD.

    J Leukoc Biol. 1985 Dec;38(6):735-46.PMID: 3934302 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Immunomodulation of nodal lymphocytes in head and neck cancer.

    Schuller DE, Libby DH, Rinehart JJ, Milo GG, Koolemans-Beynen A.

    Arch Otolaryngol. 1985 Jul;111(7):465-8.PMID: 3893401 [PubMed - indexed for MEDLINE]Related articles

    50.

    Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.

    Sadlik JR, Hoyer M, Leyko MA, Horvat R, Parmely M, Whitacre C, Zwilling B, Rinehart JJ.

    Cancer Res. 1985 May;45(5):1940-5.PMID: 3921233 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...